by Shana Cristoferi | Jul 2, 2019 | Appili Therapeutics, News
Appili’s multi-drug resistant antibiotic program has the potential to address public health threats for both military and civilian populations worldwide. HALIFAX, Nova Scotia, July 2, 2019 – Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a...